Lefex® 500
Levofloxacin Hemihydrate
Lefex® 500 contains levofloxacin 500 mg (as levofloxacin hemihydrate), a broad-spectrum fluoroquinolone antibiotic used for susceptible bacterial infections. Chemically levofloxacin is a chiral fluorinated carboxyquinolone. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby blocking DNA replication and producing a bactericidal effect.
Product Specifications
| Therapeutic Class | Antibiotic |
| Dosage Form | Tablet |
| Strength | 500 mg |
| Composition | Each film coated tablet contains Levofloxacin Hemihydrate USP equivalent to Levofloxacin 500 mg. |
| Pack Sizes | Lefex 500 Tablet: Each box contains 3 blister strips of 10 tablets. |
Detailed Information
Levofloxacin is indicated for the treatment of mild, moderate and severe infections caused by susceptible strains of the designated micro-organisms in the condition listed below: • Acute maxillary sinusitis due to Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis. • Acute bacterial exacerbation of chronic bronchitis due to Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis. • Community-acquired pneumonia due to Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Chlamydia pneumoniae, Legionella pneumophila, or Mycoplasma pneumoniae. • Uncomplicated & complicated urinary tract infections due to Escherichia coli, Klebsiella pneumoniae, or Staphylococcus saprophyticus. • Acute pyelonephritis caused by Escherichia coli. • Uncomplicated & complicated skin and soft tissue infections including abscesses, cellulitis, furuncles, impetigo, pyoderma, wound infections, due to Staphylococcus aureus, Streptococcus pyogenes, Proteus mirabilis or Enterococcus faecalis. • Enteric infections caused by Enterobacter sp., Escherichia coli, Campylobacter sp., Vibrio cholerae, Shigella sp., Salmonella sp.